Treatments to Stop Alzheimer’s Step Closer as Scientists Discover Key Inhibitor Molecule

This undated file combo image provided by Merck & Co., shows a cross section of a normal brain, right, and one of a brain damaged by advanced Alzheimer's disease. Researchers said an experimental drug from the biotech company Genentech failed to slow mental decline in tests on more than 500 people with mild to moderate Alzheimer's disease. (AP Photo/Merck & Co.)
This undated file combo image provided by Merck & Co., shows a cross section of a normal brain, right, and one of a brain damaged by advanced Alzheimer's disease. Researchers said an experimental drug from the biotech company Genentech failed to slow mental decline in tests on more than 500 people with mild to moderate Alzheimer's disease. (AP Photo/Merck & Co.)
This undated file combo image provided by Merck & Co., shows a cross section of a normal brain, right, and one of a brain damaged by advanced Alzheimer’s disease. (AP Photo/Merck & Co.)
(Medical News Today) – Scientists have discovered a molecule that can interrupt an important stage in the development of Alzheimer’s disease. The molecule sticks to faulty proteins and stops them forming toxic clusters in the brain.

The UK and Swedish researchers suggest their finding will help the discovery of drugs that could halt Alzheimer’s disease progression.

They write about their discovery and its implications in the journal Nature Structural & Molecular Biology.

Lead author Dr. Samuel Cohen – a research fellow at St John’s College in Cambridge, UK – says with studies like theirs, we are beginning to reap the rewards of the extensive work that has been done to increase our understanding of the microscopic processes involved in the development of Alzheimer’s.

READ MORE

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.